Pre-ICU medication vulnerability and healthcare-access barriers associated with unplanned intensive care admission among cancer patients: A case-control study

BackgroundUnplanned intensive care unit (ICU) admission is a critical event in the cancer trajectory and is associated with substantial mortality. Medication-related vulnerabilities and healthcare-access barriers may contribute to acute deterioration but remain insufficiently studied together.ObjectiveTo identify medication-related and healthcare-access factors independently associated with unplanned ICU admission among adults with cancer.MethodsThis hospital-based case-control study was conducted at a tertiary oncology centre. Cases were adults with cancer with unplanned ICU admission (n = 150), and controls were adults with cancer admitted to wards or day-care units without ICU requirement (n = 150), frequency-matched by age group, sex, and cancer type. Medication vulnerabilities and healthcare-access barriers were assessed using medical records and structured interviews. Multivariable logistic regression was performed to estimate adjusted odds ratios (aORs) with 95% confidence intervals (CIs).ResultsCases had higher prevalence of polypharmacy (64.0% vs 38.7%), clinically significant drug-drug interactions (42.0% vs 20.7%), and medication non-adherence (51.3% vs 29.3%). Financial barriers (58.7% vs 34.7%) and delayed care-seeking (46.0% vs 24.0%) were also more frequent. After adjustment, financial barriers (aOR 2.31, 95% CI 1.34-3.99), drug-drug interactions (2.14, 1.19-3.85), delayed care-seeking (2.08, 1.16-3.72), polypharmacy (2.05, 1.21-3.47), and non-adherence (1.94, 1.12-3.36) remained independently associated with unplanned ICU admission. ICU mortality was 32.0%.ConclusionMedication vulnerabilities and healthcare-access barriers were associated with unplanned ICU admission. These findings identify potentially modifiable areas for further evaluation, but the case-control design does not establish that interventions targeting these factors would directly reduce ICU admissions.

Authors

Institutions

Publication Details

Journal
Journal of Oncology Pharmacy Practice
Published
2026-10-29
DOI
https://doi.org/10.1177/10781552261503088
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pre-ICU medication vulnerability and healthcare-access barriers associated with unplanned intensive care admission among cancer patients: A case-control study

Allen Kuriakose, Shaba Chinnu Thomas, Ameerunnisha Begum
1 links
Journal of Oncology Pharmacy Practice
Pharmaceutical Practices and Patient Outcomes
article

Pre-ICU medication vulnerability and healthcare-access barriers associated with unplanned intensive care admission among cancer patients: A case-control study

Allen Kuriakose, Shaba Chinnu Thomas, Ameerunnisha Begum
article en

Abstract

BackgroundUnplanned intensive care unit (ICU) admission is a critical event in the cancer trajectory and is associated with substantial mortality. Medication-related vulnerabilities and healthcare-access barriers may contribute to acute deterioration but remain insufficiently studied together.ObjectiveTo identify medication-related and healthcare-access factors independently associated with unplanned ICU admission among adults with cancer.MethodsThis hospital-based case-control study was conducted at a tertiary oncology centre. Cases were adults with cancer with unplanned ICU admission (n = 150), and controls were adults with cancer admitted to wards or day-care units without ICU requirement (n = 150), frequency-matched by age group, sex, and cancer type. Medication vulnerabilities and healthcare-access barriers were assessed using medical records and structured interviews. Multivariable logistic regression was performed to estimate adjusted odds ratios (aORs) with 95% confidence intervals (CIs).ResultsCases had higher prevalence of polypharmacy (64.0% vs 38.7%), clinically significant drug-drug interactions (42.0% vs 20.7%), and medication non-adherence (51.3% vs 29.3%). Financial barriers (58.7% vs 34.7%) and delayed care-seeking (46.0% vs 24.0%) were also more frequent. After adjustment, financial barriers (aOR 2.31, 95% CI 1.34-3.99), drug-drug interactions (2.14, 1.19-3.85), delayed care-seeking (2.08, 1.16-3.72), polypharmacy (2.05, 1.21-3.47), and non-adherence (1.94, 1.12-3.36) remained independently associated with unplanned ICU admission. ICU mortality was 32.0%.ConclusionMedication vulnerabilities and healthcare-access barriers were associated with unplanned ICU admission. These findings identify potentially modifiable areas for further evaluation, but the case-control design does not establish that interventions targeting these factors would directly reduce ICU admissions.

Journal of Oncology Pharmacy Practice
Mount Zion Medical College (IN), Saveetha University (IN)
Good health and well-being, Reduced inequalities
Openalex Percentile: Top 15%
Pharmaceutical Practices and Patient Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon